Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 269

1.

A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts.

Althoff KN, Rebeiro PF, Hanna DB, Padgett D, Horberg MA, Grinsztejn B, Abraham AG, Hogg R, Gill MJ, Wolff MJ, Mayor A, Rachlis A, Williams C, Sterling TR, Kitahata MM, Buchacz K, Thorne JE, Cesar C, Cordero FM, Rourke SB, Sierra-Madero J, Pape JW, Cahn P, McGowan C; North American Aids Cohort Collaboration on Research and Design (NA-ACCORD) and Caribbean, Central and South America Network for Hiv Epidemiology (CCASAnet).

J Int AIDS Soc. 2016 Apr 4;19(1):20707. doi: 10.7448/IAS.19.1.20707. eCollection 2016.

2.

Tobacco Smoking Is Not Associated With Accelerated Liver Disease in Human Immunodeficiency Virus-Hepatitis C Coinfection: A Longitudinal Cohort Analysis.

Costiniuk CT, Brunet L, Rollet-Kurhajec KC, Cooper CL, Walmsley SL, Gill MJ, Martel-Laferriere V, Klein MB.

Open Forum Infect Dis. 2016 Mar 7;3(2):ofw050. doi: 10.1093/ofid/ofw050. eCollection 2016 Mar.

3.

Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study.

May MT, Vehreschild JJ, Trickey A, Obel N, Reiss P, Bonnet F, Mary-Krause M, Samji H, Cavassini M, Gill MJ, Shepherd LC, Crane HM, d'Arminio Monforte A, Burkholder GA, Johnson MM, Sobrino-Vegas P, Domingo P, Zangerle R, Justice AC, Sterling TR, Miró JM, Sterne JA; Antiretroviral Therapy Cohort Collaboration (ART-CC).

Clin Infect Dis. 2016 Jun 15;62(12):1571-7. doi: 10.1093/cid/ciw183. Epub 2016 Mar 29.

4.

A Case of Long-Term Seronegative Human Immunodeficiency Virus (HIV) Infection: The Importance of the Humoral Response to HIV.

Siemieniuk RA, van der Meer F, van Marle G, Gill MJ.

Open Forum Infect Dis. 2015 Dec 23;3(1):ofv209. doi: 10.1093/ofid/ofv209. eCollection 2016 Jan.

5.

Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients.

Baril JG, Angel JB, Gill MJ, Gathe J, Cahn P, van Wyk J, Walmsley S.

PLoS One. 2016 Feb 5;11(2):e0148231. doi: 10.1371/journal.pone.0148231. eCollection 2016. Review.

6.

Maintaining the continuity of HIV-care records for patients transferring care between centers: challenges, workloads, needs and risks.

Gill MJ, Ody M, Lynch T, Jessiman-Perreault L, Krentz HB.

AIDS Care. 2016 Aug;28(8):1073-8. doi: 10.1080/09540121.2016.1139042. Epub 2016 Feb 1.

PMID:
26829326
7.

Treatment outcomes with telaprevir-based therapy for HIV/hepatitis C coinfected patients are comparable with hepatitis C monoinfected patients.

O'Neil CR, Pang JX, Lee SS, Swain MG, Burak KW, Klein P, Myers RP, Kapler J, Gill MJ, Labrie M, Coffin CS.

Can J Infect Dis Med Microbiol. 2015 Nov-Dec;26(6):293-6. No abstract available.

8.

How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World?

Saeed S, Strumpf EC, Walmsley SL, Rollet-Kurhajec K, Pick N, Martel-Laferrière V, Hull M, Gill MJ, Cox J, Cooper C, Klein MB; Canadian Co-Infection Cohort Study.

Clin Infect Dis. 2016 Apr 1;62(7):919-26. doi: 10.1093/cid/civ1222. Epub 2016 Jan 6.

9.

Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy.

Cain LE, Saag MS, Petersen M, May MT, Ingle SM, Logan R, Robins JM, Abgrall S, Shepherd BE, Deeks SG, Gill MJ, Touloumi G, Vourli G, Dabis F, Vandenhende MA, Reiss P, van Sighem A, Samji H, Hogg RS, Rybniker J, Sabin CA, Jose S, Del Amo J, Moreno S, Rodríguez B, Cozzi-Lepri A, Boswell SL, Stephan C, Pérez-Hoyos S, Jarrin I, Guest JL, Monforte AD, Antinori A, Moore R, Campbell CN, Casabona J, Meyer L, Seng R, Phillips AN, Bucher HC, Egger M, Mugavero MJ, Haubrich R, Geng EH, Olson A, Eron JJ, Napravnik S, Kitahata MM, Van Rompaey SE, Teira R, Justice AC, Tate JP, Costagliola D, Sterne JA, Hernán MA; Antiretroviral Therapy Cohort Collaboration, the Centers for AIDS Research Network of Integrated Clinical Systems, and the HIV-CAUSAL Collaboration.

Int J Epidemiol. 2015 Dec 31. pii: dyv295. [Epub ahead of print]

PMID:
26721599
10.

Montreal Cognitive Assessment Performance in HIV/AIDS: Impact of Systemic Factors.

Koenig N, Fujiwara E, Gill MJ, Power C.

Can J Neurol Sci. 2016 Jan;43(1):157-62. doi: 10.1017/cjn.2015.306. Epub 2015 Dec 4.

PMID:
26635008
11.

Mortality in migrants with HIV in western Europe.

Gill MJ, Krentz HB.

Lancet HIV. 2015 Dec;2(12):e508-9. doi: 10.1016/S2352-3018(15)00210-6. Epub 2015 Nov 18. No abstract available.

PMID:
26614963
12.

Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study.

Carvalhal A, Gill MJ, Letendre SL, Rachlis A, Bekele T, Raboud J, Burchell A, Rourke SB; Centre for Brain Health in HIV/AIDS.

J Neurovirol. 2016 Jun;22(3):349-57. doi: 10.1007/s13365-015-0404-5. Epub 2015 Nov 16.

PMID:
26572786
13.

Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis.

Antiretroviral Therapy Cohort Collaboration (ART-CC); Canadian Observational Cohort Collaboration (CANOC); UK Collaborative HIV Cohort Study (UK CHIC); Collaboration of Observational HIV Epidemiological Research in Europe (COHERE), May MT, Gill MJ, Wittkop L, Klein M, Sabin C, Harrigan PR, Dunn D, Vehreschild JJ, Rubio R, Mocroft A, Cavassini M, Reiss P, Monforte AD, Zangerle R, Ingle SM, Hill T, Jose S, Sterne JA.

AIDS. 2016 Jan 28;30(3):503-13. doi: 10.1097/QAD.0000000000000941.

14.

The Impact of Non-Antiretroviral Polypharmacy on the Continuity of Antiretroviral Therapy (ART) Among HIV Patients.

Krentz HB, Gill MJ.

AIDS Patient Care STDS. 2016 Jan;30(1):11-7. doi: 10.1089/apc.2015.0199. Epub 2015 Nov 6.

PMID:
26544766
15.

Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study.

Silverberg MJ, Lau B, Achenbach CJ, Jing Y, Althoff KN, D'Souza G, Engels EA, Hessol NA, Brooks JT, Burchell AN, Gill MJ, Goedert JJ, Hogg R, Horberg MA, Kirk GD, Kitahata MM, Korthuis PT, Mathews WC, Mayor A, Modur SP, Napravnik S, Novak RM, Patel P, Rachlis AR, Sterling TR, Willig JH, Justice AC, Moore RD, Dubrow R; North American AIDS Cohort Collaboration on Research and Design of the International Epidemiologic Databases to Evaluate AIDS.

Ann Intern Med. 2015 Oct 6;163(7):507-18. doi: 10.7326/M14-2768.

16.

Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals.

Lee Z, Nishikawa S, Gao S, Eksteen JB, Czub M, Gill MJ, Osiowy C, van der Meer F, van Marle G, Coffin CS.

PLoS One. 2015 Sep 21;10(9):e0137568. doi: 10.1371/journal.pone.0137568. eCollection 2015.

17.

Decision making under explicit risk is impaired in individuals with human immunodeficiency virus (HIV).

Fujiwara E, Tomlinson SE, Purdon SE, Gill MJ, Power C.

J Clin Exp Neuropsychol. 2015;37(7):733-50. doi: 10.1080/13803395.2015.1057481. Epub 2015 Jul 24.

PMID:
26207583
18.

Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration.

May MT, Justice AC, Birnie K, Ingle SM, Smit C, Smith C, Neau D, Guiguet M, Schwarze-Zander C, Moreno S, Guest JL, Monforte Ad, Tural C, Gill MJ, Bregenzer A, Kirk O, Saag M, Sterling TR, Crane HM, Sterne JA.

J Acquir Immune Defic Syndr. 2015 Jul 1;69(3):348-54. doi: 10.1097/QAI.0000000000000603.

19.

Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients.

Antiretroviral Therapy Cohort Collaboration (ART-CC), Vandenhende MA, Ingle S, May M, Chene G, Zangerle R, Van Sighem A, Gill MJ, Schwarze-Zander C, Hernandez-Novoa B, Obel N, Kirk O, Abgrall S, Guest J, Samji H, D'Arminio Monforte A, Llibre JM, Smith C, Cavassini M, Burkholder GA, Shepherd B, Crane HM, Sterne J, Morlat P.

AIDS. 2015 Jan 28;29(3):373-83. doi: 10.1097/QAD.0000000000000544. Erratum in: AIDS. 2015 Sep 10;29(14):1907.

PMID:
25686685
20.

Editorial commentary: Myocardial infarction in HIV-infected persons: time to focus on the silent elephant in the room?

Gill MJ, Costagliola D.

Clin Infect Dis. 2015 May 1;60(9):1424-5. doi: 10.1093/cid/civ016. Epub 2015 Jan 16. No abstract available.

Items per page

Supplemental Content

Write to the Help Desk